Skip to main content
TipRanks
Go Ultimate75% OFF

Data Horizon Co., Ltd. (3628) AI Stock Analysis

0 Followers
JP:3628

Data Horizon Co., Ltd.

(TSE/TYO:3628)

Select Model
Rating:46Neutral
Price Target:JPY 703.00â–¼(-2.90% Downside)
Action:reiterated
Date:10/14/26

The overall score is heavily constrained by a weak financial foundation, marked by extreme leverage and negative cash flows, despite a recent return to net profitability. Positive technical momentum provides a notable counterbalance, but the high P/E ratio and lack of dividends do little to offset the fundamental risks.

Positive Factors
Steady Revenue GrowthSteady multi-year revenue growth, including 6.8% in the latest annual period, indicates resilient demand for the company’s offerings. Continued top-line expansion can support operating scale and investment in data solutions, although growth alone does not resolve profitability and cash-conversion challenges.
Negative Factors
Very High LeverageVery high debt relative to equity reduces financial flexibility and leaves the company more exposed to refinancing pressure and interest obligations. The small equity base also makes leverage more sensitive to earnings swings, potentially limiting investment capacity during periods of weaker performance.

Data Horizon Co., Ltd. (3628) vs. iShares MSCI Japan ETF (EWJ)

-30%-20%-10%0%10%20%30%40%JP:3628+32.12%EWJ+13.61%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
JPY 8.85B
Dividend Yield
―
Average Volume (3M)
9,121
Price to Earnings (P/E)
93.6
Beta (1Y)
-0.14
Revenue Growth
6.18%
EPS Growth
95.42%
Country
Japan
Employees
365
Sector
Healthcare
Sector Strength
51
Industry
Medical - Healthcare Information Services

Data Horizon Co., Ltd. Business Overview & Revenue Model

Company Description

Data Horizon Corporation offers specialized health data support solutions to insurance providers across Japan. The company develops and supplies medical information services, encompassing health-relevant data and notifications about generic drugs, al...

Data Horizon Co., Ltd. Financial Statement Overview

Summary

Financial health is poor. While revenue grew 6.8% and the company returned to net profitability, the balance sheet is critically overleveraged with a debt-to-equity ratio of 11.1, and cash flows are negative, indicating earnings are not converting to cash.

Income Statement

45Neutral

Balance Sheet

20Very Negative

Cash Flow

25Negative
Financial statement breakdown
BreakdownTTMMar 2026Jun 2024Jun 2023Jun 2022Jun 2021
Income Statement
Total Revenue5.14B5.14B5.14B5.01B4.41B2.99B
Gross Profit1.32B1.79B2.07B1.90B1.18B1.44B
EBITDA82.80M387.70M82.80M-148.66M-1.59M-136.32M
Net Income-3.95B268.00M-3.95B-807.18M-664.86M-410.80M
Balance Sheet
Total Assets7.79B8.36B7.79B7.90B7.44B2.26B
Cash, Cash Equivalents and Short-Term Investments1.22B1.02B1.22B1.42B1.08B379.98M
Total Debt4.81B5.29B4.81B2.46B1.47B400.00M
Total Liabilities7.57B7.88B7.57B4.68B3.42B977.21M
Stockholders Equity221.67M476.48M221.67M3.19B3.97B1.26B
Cash Flow
Free Cash Flow-154.63M-309.73M-1.89B64.81M-253.54M-747.41M
Operating Cash Flow-145.58M-219.34M-1.88B120.13M-198.37M-442.98M
Investing Cash Flow-177.67M-797.68M-673.71M-789.14M-3.51B-572.80M
Financing Cash Flow410.07M809.00M2.35B1.02B4.41B331.20M

Data Horizon Co., Ltd. Technical Analysis

Technical Analysis SentimentPositive
Last Price724.00

Price Trends

50DMA688.00Positive
100DMA623.54Positive
200DMA572.98Positive

Market Momentum

MACD-0.61Positive
RSI55.25Neutral
STOCH66.48Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3628, the sentiment is Positive. The current price of 724.00 is above the 20-day moving average (MA) of 701.40, above the 50-day MA of 688.00, and above the 200-day MA of 572.98, indicating a bullish trend. The MACD of -0.61 indicates Positive momentum. The RSI at 55.25 is Neutral, neither overbought nor oversold. The STOCH value of 66.48 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:3628.

Data Horizon Co., Ltd. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

JP:3628 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
JP:2413JP:241379OutperformJPY 1.28T26.3611.33%1.19%9.48%2.08%
JP:4480JP:448063NeutralJPY 80.31B42.3312.35%―24.03%34.50%
JP:4483JP:448361NeutralJPY 260.81B34.63―0.45%20.50%19.27%
JP:4438JP:443854NeutralJPY 2.38B-4.42――14.84%30.67%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
JP:3628JP:362846NeutralJPY 8.97B93.56――6.18%95.42%

* Healthcare Sector Average

Performance Comparison

-40%-20%0%20%JP:3628JP:2413JP:4480JP:4438JP:4483Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
JP:3628 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
JP:3628Data Horizon Co., Ltd.724.00174.0031.64%
JP:2413M3 1844.50-855.94-31.70%
JP:4480Medley, Inc.2608.00331.0014.54%
JP:4438Welby Inc.270.00-87.00-24.37%
JP:4483JMDC Inc.3850.00-508.80-11.67%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 14, 2026